Cargando…
448 Establishing the efficacy of naturally occurring endocannabinoid-like substance in an in vitro model of Fragile X Tremor/Ataxia Syndrome (FXT/AS)
OBJECTIVES/GOALS: FXT/AS is a devastating, rare neurological syndrome that negatively impacts movement and cognition and is suspected to induce mitochondria dysfunction. Currently, no effective pharmacological treatments for FXTAS exist. The goal is to restore mitochondrial viability using endocanna...
Autores principales: | Brown, Collis, Sobrian, Sonya, Hudson, Tamaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129698/ http://dx.doi.org/10.1017/cts.2023.475 |
Ejemplares similares
-
400 Potential Drug Therapy for Fragile X Tremor/Ataxia Syndrome
por: Brown, Collis, et al.
Publicado: (2022) -
95355 Potential Drug Therapy for Fragile X Tremor/Ataxia Syndrome
por: Brown, Collis, et al.
Publicado: (2021) -
Dementia in Fragile X-associated Tremor/Ataxia
Syndrome
por: Nitrini, Ricardo, et al.
Publicado: (2010) -
A Case of Fragile-X-Associated Tremor/Ataxia Syndrome Without Tremor
por: Lee, Woong-Woo, et al.
Publicado: (2023) -
Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
por: Berman, Robert F, et al.
Publicado: (2014)